Literature DB >> 16330810

Sclerostin and Wnt signaling--the pathway to bone strength.

Susan M Ott.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16330810     DOI： 10.1210/jc.2005-2370

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  27 in total

1.  Big endothelin changes the cellular miRNA environment in TMOb osteoblasts and increases mineralization.

Authors:  Michael G Johnson; Jasmin Kristianto; Baozhi Yuan; Kathryn Konicke; Robert Blank
Journal:  Connect Tissue Res       Date:  2014-08       Impact factor: 3.417

Review 2.  Breaking new ground to build bone.

Authors:  Lauren A Kingsley; John M Chirgwin; Theresa A Guise
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-20       Impact factor: 11.205

Review 3.  Regulatory pathways revealing new approaches to the development of anabolic drugs for osteoporosis.

Authors:  T J Martin; N A Sims; K W Ng
Journal:  Osteoporos Int       Date:  2008-03-13       Impact factor: 4.507

Review 4.  The osteocyte: an endocrine cell ... and more.

Authors:  Sarah L Dallas; Matthew Prideaux; Lynda F Bonewald
Journal:  Endocr Rev       Date:  2013-04-23       Impact factor: 19.871

Review 5.  Giant cell tumor of bone: current treatment options.

Authors:  Keith M Skubitz
Journal:  Curr Treat Options Oncol       Date:  2014-09

Review 6.  A review of osteocyte function and the emerging importance of sclerostin.

Authors:  Jocelyn T Compton; Francis Y Lee
Journal:  J Bone Joint Surg Am       Date:  2014-10-01       Impact factor: 5.284

Review 7.  WNT signaling in bone development and homeostasis.

Authors:  Zhendong Zhong; Nicole J Ethen; Bart O Williams
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2014-09-30       Impact factor: 5.814

Review 8.  Molecular biology of bone remodeling: implications for new therapeutic targets for osteoporosis.

Authors:  J Chris Gallagher; A J Sai
Journal:  Maturitas       Date:  2010-01-29       Impact factor: 4.342

9.  Sclerostin antibody increases bone volume and enhances implant fixation in a rat model.

Authors:  Amarjit S Virdi; Min Liu; Kotaro Sena; James Maletich; Margaret McNulty; Hua Zhu Ke; Dale R Sumner
Journal:  J Bone Joint Surg Am       Date:  2012-09-19       Impact factor: 5.284

10.  OPG and RANKL mRNA and protein expressions in the primary and secondary metaphyseal trabecular bone of PTH-treated rats are independent of that of SOST.

Authors:  Giuliana Silvestrini; Paola Ballanti; Mariangela Sebastiani; Martina Leopizzi; Maura Di Vito; Ermanno Bonucci
Journal:  J Mol Histol       Date:  2007-12-20       Impact factor: 2.611
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.